BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Deals

  J&J Snaps Up Momenta Pharmaceuticals in $6.5 Billion All-Cash Deal

  J&J said the acquisition will allow its subsidiary, Janssen Pharmaceutical, to broaden its leadership in immune-mediated diseases and drive further growth through expansion into autoantibody-driven disease.

  August 19, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Sorrento Abruptly Ousts CFO Following Stock Manipulation Report

  In its filing, Sorrento did not provide a reason for Shao’s termination.

  August 19, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Novateur Ventures: Overlooked Generic Drug Strategy May Prevent COVID-19’s Cytokine Storm

  Two generic anti-inflammatory drugs typically used in asthma treatments are being proposed for use with COVID-19 because of their potential to dampen disease progression and severity.

  August 19, 2020

   · 

  4 min read

   · 

  Gail Dutton
• 

  Career Advice

  3 Ways to Use Your Former Commute Time to Advance Your Career

  Now that a majority of us are working remotely, and it may stay like that for the foreseeable future, one thing we’ve left behind is the commute to the office.

  August 19, 2020

   · 

  2 min read

   · 

  Laura Brothers
• 

  Business

  Regeneron and Roche Partner to Increase Supply of COVID-19 Antibody Cocktail

  Regeneron will distribute REGN-COV-2 in the U.S. and Roche will handle distribution outside the U.S.

  August 19, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Pharm Country

  Takeda Continues to Shed OTC Business Offerings with $2.3 Billion Deal

  Takeda continues to divest its over-the-counter business operations and has struck a deal for its U.S. offerings with The Blackstone Group, a U.S.-based investment fund valued at $2.37 billion.

  August 19, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  IBRI Licenses Rapid-Testing Technology for Infectious Diseases

  Point-of-care testing is a critical tool in the battle against COVID-19, and researchers in Indiana are working around the clock to deliver rapid tests with high specificity.

  August 19, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  FDA Turns Down BioMarin’s Hemophilia A Gene Therapy

  The agency indicated that they had completed the review cycle for the application but the application was not ready for approval in its current form.

  August 19, 2020

   · 

  4 min read

   · 

  Mark Terry
• 

  BioSpace Global Roundup, Aug. 20

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  August 19, 2020

   · 

  4 min read

   · 

  Alex Keown
• 

  FDA

  Mylan Wins Approval for First Generic to Biogen’s MS Drug Tecfidera

  This morning, Mylan announced the launch of its new generic offering, dimethyl fumarate delayed-release capsules for the treatment of relapsing forms of multiple sclerosis.

  August 19, 2020

   · 

  2 min read

   · 

  Alex Keown